Member Info for Midas3316

Please. My pleasure. Are you a long term holder pickled ? What's your target price.

I've only ever day traded this share. Made a few grand in a couple of hours when it went crazy that day. I never got back in like I said as the outlook never really improved. If you look back you will also see that I was the first to mention that the sales of the FF + wasn't increasing in single digits and later gave the link from an old business manual of how companies have done this for years to fool people regarding sales figures or for genuine reasons like the pharmaceutical company I deal with uses. I was only ever thinking about getting back in at .5 as I am now at .2 is with the hope of another ramping rampage. I don't ever believe there will be genuine results that will raise the share price with relevant figures. I think it will only move with a day of ramping. Company wise. ....pathetic. .... Revenue.....an absolute joke.....I really do believe the best they can hope for is to break even

I might take a gamble at around 0.20......current valuation is ridiculous...good product....pathetic management......I think the best they can hope for is break even in a couple of years and maybe small profit after that...but current valuation....LOL

It's unbelievable how they haven't released another statement regarding their own big ramp. I know they have been in trouble in the past for misleading statements. What on earth is going on. Surely they need to at least update on that so called big deal

Just to clarify...It can take up to a year to recruit the patients for a clinical trial...then up to 2 or 3 years for the trial....then if all is well a year or two after that if all the boxes are ticked....they might make it to market.....Its a very slow process...but this could also be huge for red x if all goes well....worth a gamble at these levels......normally the big players don't invest until its about to go on sale....as they know if its a good product it will multiply many times again...

Then maybe if things are good. You might even if after passing all hurdles see the drug on the market about 3 or 4 years after that

I woud guess in around 2 years and with a further fund raise they should have it going. I work with clinical trails within the NHS and these things take forever. Very very few ever make money

Don't you agree that if it were to make money it would have happened by now. The vast majority of new supplements and health products hit their peak sales within 18 months of launch and if they are any good they might keep steady or if not they will drift back down on sales.

I thought the only people that bought this would Be day traders. Surely this can't go anywhere. It's ran by a couple of zombies

Your not holding shares are you ?

Tom winnifrith. An obnoxious man. But on this occasion he was right. He hates seeing people suckered into aim shares that do their own ramping and lead the foolish into buying their shares when the company has no way of making it

I honestly don't believe there are people who believe this has an actual chance of making any decent money. It's a good rampers share and that's it. This is an old post but still very relevant. If you look at the AIM market it is full of companies that have been promising the earth for years, but have yet to actually achieve much of any real substance. One such company which would definitely appear to fall into that bracket is Provexis (PXS), which for almost as long as I can remember has been banging on about its patented Fruitflow tomato extract, which has been proven to help prevent heart attacks, strokes and venous thrombosis, via platelet inhibitors which the product contains. At a time when so many people are more conscious about their health than ever before and regularly take supplements to improve it, it sounds like the company could well be onto something interesting and which the consumer might demand. But then we take a look at Fruitflow itself and its history, which dates right back to 2009 when the European Commission authorised the health claim that it ‘helps maintain normal platelet aggregation, which contributes to healthy blood flow’. Then in mid-2010 Provexis announced it had entered into an agreement with DSM Nutritional Products, one of the world’s biggest suppliers of vitamins and similar, to bring Fruitflow to market. That agreement was subsequently revised in June 2015, making it more favourable for Provexis in terms of costs and fixed overheads relating to the product. At the time the company mentions that under the new terms it would have been 101% better off in terms of profit from sales for the previous three years. 101% of near to zero is still next to nothing. What it isn’t so quick to quantify though is what that would have represented in terms of actual ‘profit’, because the reality is that all it would have done is slightly reduce the level of losses being made during that period. This has been a common theme for the company, and although it is quick to mention that profit from the agreement with DSM amounted to revenue of just £92,000 for the six months ended March 31 2016. That resulted in an underlying loss from operations of £385,000, with over £350,000 of that being due to admin expenses, and Provexis made a net loss of some £440,000 for the period. My big concern here would be that given the product has been around for more than seven years now, and has had a tie up with DSM for more than six years, then surely it would have achieved far more with it already than it has done, if the product was ever really going to take off in the way the company hoped when it came up with the idea. Provexis did launch a new Fruitflow and Omega-3 dietary supplement back in June, and it still remains to be seen how that translates into financial results, but I would be surprised if it changed overall profitability enough to really make the

Bod buys in over 30% of cases as reported by several agencies including the FT. Are done with money/ bonuses given with the clear intention that they buy shares with them. Just as new directors to the board purchase shares upon joinIng - in just about every case that is paid from the signing bonus with the intention they buy shares. There are many cases of directors quoting this when they leave a company. Stating they only purchased with the money they were given to purchase. Not through their own choice

Like most have said in the past . They have probably missed their opportunity to make any money from this "new wonderful product". If they had pushed this from the start with decent advertising etc they may have been in a different situation. There are many more products available now and they will just blend into the other supplements and vitamins on the shelf. They are moving forward but at best break even is about as much as they can hope for. I've never understood the valuation here. Unless they are researching some new cure for cancer that we don't know about. Don't believe the resident rampers here. They are not long term holders. They have this act of pretending to be genuine believers of this clap trap company

I've bought this in the past and held on most occasions for a matter of hours. Made a decent amount on a rampers afternoon here but like most would never dream of holding it long term like a real share. Even the die hards have to agree the turnover is nothing other than laughable. They are increasing their turnover and have new projects on the go but even increasing turnover in those areas at the 100% plus rates year on year it will still be several years before they reach a valuation of what they are already now. Fruit flow plus sales were an absolute joke. I was the first to mention the fact that the order numbers did not increase in single units. That's an old trick from the 50s when the companies would show the bank manager how many orders they had achieved. I don't believe for one minute these people are long term holders. Just others like me waiting for the rampers to return. Surely they have realised that if they were to make any profit worthwhile they would have been there by now. They are at last making moves forward but at best they might make a valuation of half of what they are now in a few years time.

I keep looking back here to see if there is any sign of the rampers returning. Made a tidy profit one afternoon here after the rampers really got it moving. Otherwise I think most will agree it's a pretty dire company

The spread shown on here is always miles out. It's .61 to buy right now. Less than what they have as mid price.

I would think it's more akin to puss ip in a brewery style management. Take the money each month and move on when the games over

Exactly. I think the local Chinese could be a better bet. These are valued at over £5m. Have never made a profit and the brokers don't expect them to ever reach break even. Yet a good Chinese can be picked up for £200k making £40k a year profit. So doing the maths. For the same valuation of this company you could buy 25 Chinese take aways and make net profit of around £1million. LOL. That's fact. Makes the valuation of this look absolutely ridiculous

I did say a few months back when they were 20p that they would drop to 10p and I might make a risky gamble on them. I've done some research and now believe they will fall to at least 6p. I'll wait and buy then for a gamble. A change of bod might make it move. Though I still think the business idea is pretty lame. As so does the rest of the market I see.